CA2110575A1 - Utilisation de derives de tetrahydrobenzazepine dans le traitement de l'hypertension et de la migraine spleniques - Google Patents
Utilisation de derives de tetrahydrobenzazepine dans le traitement de l'hypertension et de la migraine spleniquesInfo
- Publication number
- CA2110575A1 CA2110575A1 CA002110575A CA2110575A CA2110575A1 CA 2110575 A1 CA2110575 A1 CA 2110575A1 CA 002110575 A CA002110575 A CA 002110575A CA 2110575 A CA2110575 A CA 2110575A CA 2110575 A1 CA2110575 A1 CA 2110575A1
- Authority
- CA
- Canada
- Prior art keywords
- tetrahydro
- benzazepine
- compound
- hydroxy
- methoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9113377.7 | 1991-06-21 | ||
| GB919113377A GB9113377D0 (en) | 1991-06-21 | 1991-06-21 | Medicaments |
| GB919113379A GB9113379D0 (en) | 1991-06-21 | 1991-06-21 | Medicaments |
| GB9113379.3 | 1991-06-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2110575A1 true CA2110575A1 (fr) | 1993-01-07 |
Family
ID=26299102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002110575A Abandoned CA2110575A1 (fr) | 1991-06-21 | 1992-06-17 | Utilisation de derives de tetrahydrobenzazepine dans le traitement de l'hypertension et de la migraine spleniques |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0589973A1 (fr) |
| JP (1) | JPH06508352A (fr) |
| KR (1) | KR940701258A (fr) |
| AU (1) | AU1927992A (fr) |
| CA (1) | CA2110575A1 (fr) |
| IE (1) | IE921990A1 (fr) |
| MX (1) | MX9203012A (fr) |
| PT (1) | PT100602A (fr) |
| WO (1) | WO1993000094A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211277D0 (en) | 1992-05-28 | 1992-07-15 | Glaxo Group Inc | Pharmaceutical compositions |
| WO1997035582A1 (fr) * | 1996-03-25 | 1997-10-02 | Eli Lilly And Company | Technique de traitement de la douleur due a la migraine |
| JPWO2002074746A1 (ja) * | 2001-03-16 | 2004-07-08 | 山之内製薬株式会社 | ベンゾアゼピン誘導体 |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| ATE441417T1 (de) | 2002-12-20 | 2009-09-15 | Glaxo Group Ltd | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten |
| EP2332919A3 (fr) | 2003-06-17 | 2011-10-19 | Arena Pharmaceuticals, Inc. | Procédés de préparation de 3-benzazepines |
| CN1805938B (zh) | 2003-06-17 | 2010-06-16 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物 |
| TW200510324A (en) * | 2003-08-11 | 2005-03-16 | Lilly Co Eli | 6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist |
| US8168624B2 (en) | 2004-12-21 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| NZ555482A (en) | 2004-12-23 | 2011-01-28 | Arena Pharm Inc | Compositions comprising a 5HT2C receptor modulator and 2-methylamphetamine and methods of use |
| CN101466684B (zh) | 2006-04-03 | 2012-06-20 | 艾尼纳制药公司 | 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体 |
| US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
| JP5491421B2 (ja) | 2008-03-04 | 2014-05-14 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ｃアゴニストである（ｒ）−８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンゾアゼピンに関連する中間体の調製のためのプロセス |
| EP2443080A2 (fr) | 2009-06-18 | 2012-04-25 | Arena Pharmaceuticals, Inc. | Procédés pour la préparation d'agonistes du récepteur 5-ht<sb>2c</sb> |
| WO2011153206A1 (fr) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Procédés pour la préparation d'agonistes du récepteur 5-ht2c |
| CN103189359A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的光学活性酸盐 |
| ES2704455T3 (es) | 2010-09-01 | 2019-03-18 | Arena Pharm Inc | Formas farmacéuticas de liberación modificada de agonistas de 5-HT2C útiles para la gestión del peso |
| EP2611433A2 (fr) * | 2010-09-01 | 2013-07-10 | Arena Pharmaceuticals, Inc. | Sels non hygroscopiques d'agonistes de 5-ht2c |
| EP2939677A1 (fr) | 2010-09-01 | 2015-11-04 | Arena Pharmaceuticals, Inc. | Administration de lorcasérine à des individus avec une insuffisance rénale |
| KR20130138768A (ko) * | 2010-09-01 | 2013-12-19 | 아레나 파마슈티칼스, 인크. | 5-ｈｔ2ｃ 아고니스트의 신속-용해성 투여 형태 |
| MY181736A (en) | 2012-10-09 | 2021-01-05 | Arena Pharm Inc | Method of weight management |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4659706A (en) * | 1985-12-20 | 1987-04-21 | Smithkline Beckman Corporation | Sulfinyl and sulfonyl substituted 3-benzazepines |
-
1992
- 1992-06-17 WO PCT/GB1992/001083 patent/WO1993000094A2/fr not_active Application Discontinuation
- 1992-06-17 CA CA002110575A patent/CA2110575A1/fr not_active Abandoned
- 1992-06-17 AU AU19279/92A patent/AU1927992A/en not_active Abandoned
- 1992-06-17 EP EP92912293A patent/EP0589973A1/fr not_active Withdrawn
- 1992-06-17 KR KR1019930703940A patent/KR940701258A/ko not_active Application Discontinuation
- 1992-06-17 JP JP4511087A patent/JPH06508352A/ja active Pending
- 1992-06-17 PT PT100602A patent/PT100602A/pt not_active Application Discontinuation
- 1992-06-19 MX MX9203012A patent/MX9203012A/es unknown
- 1992-07-01 IE IE199092A patent/IE921990A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX9203012A (es) | 1993-07-01 |
| EP0589973A1 (fr) | 1994-04-06 |
| IE921990A1 (en) | 1992-12-30 |
| WO1993000094A2 (fr) | 1993-01-07 |
| PT100602A (pt) | 1993-09-30 |
| KR940701258A (ko) | 1994-05-28 |
| AU1927992A (en) | 1993-01-25 |
| JPH06508352A (ja) | 1994-09-22 |
| WO1993000094A3 (fr) | 1993-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2110575A1 (fr) | Utilisation de derives de tetrahydrobenzazepine dans le traitement de l'hypertension et de la migraine spleniques | |
| AU2014323822B2 (en) | Immune adjustment compound, use thereof and pharmaceutical composition comprising same | |
| WO1999020620A1 (fr) | Derive d'isoquinoleine et medicament | |
| TWI403320B (zh) | 用於抑制ｂｃｌ蛋白和結合夥伴間之交互作用的化合物及方法 | |
| JP5575979B2 (ja) | シアノ基を含有するチエノピリジンエステル誘導体、その調製方法、使用および組成物 | |
| TW201412737A (zh) | 吡唑並［３，４－ｃ］吡啶類衍生物、其製備方法及其在醫藥上的應用 | |
| WO2000028993A1 (fr) | Ligands de serotonine en tant que composes favorisant l'erection | |
| JPS63502031A (ja) | ヒドロキシおよびアミノチオゾリル−ベンゾジアジノン化合物、これを含む強心性組成物、およびその使用 | |
| WO2016000568A1 (fr) | Composé pour le traitement de la goutte | |
| BR112019026945A2 (pt) | derivado de indol-formamida, método de preparação para ele e seu uso em medicina | |
| JP2005232179A (ja) | ３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物を含有する抗不整脈剤 | |
| PT644878E (pt) | Compostos 2,5-dio-2,5-di-hidro-1h-benzo¬b|azepina como antagonistas do receptor nmda | |
| JPH05213888A (ja) | 治療剤 | |
| CS275840B6 (en) | Process for preparing benzamides | |
| CN114516843A (zh) | 嘧啶二酮类衍生物、其制备方法及其在医药上的应用 | |
| CA3075324A1 (fr) | Derive d'indole-formamide substitue par un atome de deuterium, son procede de preparation et ses applications medicales | |
| KR100339115B1 (ko) | 결정성3-(4-헥실옥시-1,2,5-티아디아졸-3-일)-1,2,5,6-테트라하이드로-1-메틸피리딘(+)l-하이드로겐타르트레이트,이의제조방법및이를포함하는약제학적조성물 | |
| US4897423A (en) | Dinitrobenzenesulfonamides | |
| EP4174068A1 (fr) | Nouveau composé et composition pharmaceutique le comprenant pour prévenir ou traiter un cancer résistant | |
| JP5180219B2 (ja) | 新規なモルヒネ誘導体 | |
| CN114539229A (zh) | 嘧啶二酮类衍生物、其制备方法及其在医药上的应用 | |
| JP3748935B2 (ja) | オキシインドール誘導体 | |
| KR20020012314A (ko) | 빈뇨 혹은 요실금의 치료 또는 예방제 | |
| US6071968A (en) | Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant | |
| EP2964331A1 (fr) | Dérivés de pyridoindolo[b,e]azépine pentacyclique et leurs utilisations |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |